Virax Biolabs Group Limited Ordinary Shares (VRAX) Stock Price

VRAXStock

$1.45−90.57%52W

Market Cap$1.95M

P/E—

PEG Ratio—

Div yield—

Beta1.51

VRAX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-70.72%

Price vs S&P 500 (4W)-35.90%

VGM Score35.89

Book Value / Share (Quarterly)$13.08

P/TBV (Annual)0.32x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.21%

Cash Flow / Share (Quarterly)$-8.42

Price vs S&P 500 (YTD)-95.14%

Gross Margin (TTM)61.95%

Net Profit Margin (TTM)-40416.33%

EPS (TTM)$-23.09

10-Day Avg Trading Volume0.39M

EPS Excl Extra (TTM)$-23.09

Revenue Growth (5Y)-36.47%

EPS (Annual)$-12.64

ROI (Annual)-62.86%

Gross Margin (Annual)61.92%

Net Profit Margin (5Y Avg)-40961.08%

Cash / Share (Quarterly)$11.12

Revenue Growth QoQ (YoY)684.06%

ROA (Last FY)-60.35%

Revenue Growth TTM (YoY)96.37%

EBITD / Share (TTM)$-27.16

Operating Margin (TTM)-51486.08%

Cash Flow / Share (Annual)$-8.42

P/B Ratio0.26x

P/B Ratio (Quarterly)0.26x

Net Income / Employee (Annual)$-264,400

EV / Revenue (TTM)-327.78x

Net Interest Coverage (TTM)-105.63x

ROA (TTM)-71.56%

EPS Incl Extra (Annual)$-12.64

Current Ratio (Annual)9.97x

Quick Ratio (Quarterly)9.44x

3-Month Avg Trading Volume1.31M

52-Week Price Return-90.57%

Revenue / Employee (TTM)$700

Tangible BV / Share (Quarterly)$2.09

P/S Ratio (Annual)157.02x

Asset Turnover (Annual)0.00x

52-Week High$21.75

Operating Margin (5Y Avg)-44109.17%

EPS Excl Extra (Annual)$-12.64

26-Week Price Return-60.81%

Quick Ratio (Annual)9.44x

13-Week Price Return-61.74%

Total Debt / Equity (Annual)0.05x

Current Ratio (Quarterly)9.97x

Enterprise Value$-4.07M

Revenue / Share Growth (5Y)24.10%

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$700

Inventory Turnover (Annual)0.10x

Pretax Margin (Annual)-47765.06%

Cash / Share (Annual)$11.12

3-Month Return Std Dev86.91%

Gross Margin (5Y Avg)-153.69%

Net Income / Employee (TTM)$-264,400

ROE (Last FY)-66.30%

Net Interest Coverage (Annual)-92.23x

EPS Basic Excl Extra (Annual)$-12.64

Receivables Turnover (TTM)1.94x

Total Debt / Equity (Quarterly)0.05x

EPS Incl Extra (TTM)$-23.09

ROI (TTM)-72.59%

P/S Ratio (TTM)156.90x

Pretax Margin (5Y Avg)-42879.67%

Revenue / Share (Annual)$0.03

Tangible BV / Share (Annual)$52.12

Price vs S&P 500 (52W)-106.10%

Year-to-Date Return-83.22%

5-Day Price Return-21.62%

EPS Normalized (Annual)$-12.64

ROA (5Y Avg)-750.61%

Net Profit Margin (Annual)-40448.87%

Month-to-Date Return-33.61%

EBITD / Share (Annual)$-14.99

Operating Margin (Annual)-51527.62%

EPS Basic Excl Extra (TTM)$-23.09

P/TBV (Quarterly)0.32x

P/B Ratio (Annual)0.26x

Inventory Turnover (TTM)0.10x

Pretax Margin (TTM)-47726.71%

Book Value / Share (Annual)$13.08

Price vs S&P 500 (13W)-64.43%

Beta1.51x

Revenue / Share (TTM)$0.05

ROE (TTM)-77.95%

52-Week Low$1.38

gGradeB

mGradeF

vgmGradeD

VRAX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	156.9x	96.4%	62.0%	—	$1.45
IDXXIdexx Laboratories Inc	D	B	B	9.7x	12.8%	62.5%	14.3%	$560.36
LNTHLantheus Holdings, Inc	C	B	B	4.2x	2.4%	61.0%	40.7%	$99.70
NEOGNeogen Corp	C	C	A	2.9x	-0.3%	47.4%	—	$11.81
CLDXCelldex Therapeutics, Inc	F	F	C	13683.0x	-97.3%	17.6%	—	$27.53
NTLAIntellia Therapeutics, Inc	D	D	C	26.9x	12.6%	—	—	$11.42
QDELQuidelOrtho Corporation Common Stock	C	C	C	0.3x	-2.5%	44.6%	—	$12.91
ACHVAchieve Life Sciences, Inc.	F	F	B	36.8x	-89.3%	—	—	$6.38
MYGNMyriad Genetics Inc	C	C	D	0.5x	-3.2%	68.8%	—	$3.98
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	8.7x	12.3%	34.6%	—	$7.08
NNNNAnbio Biotechnology Class A Ordinary Shares	F	C	F	34.0x	-5.7%	89.0%	—	$3.13
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	59.0x	-60.8%	48.3%	—	$3.01
ICCCImmucell Corp	C	C	A	3.2x	8.5%	40.3%	—	$10.75
BMRABIOMERICA INC	B	D	B	1.9x	-16.2%	8.1%	—	$1.85
TRIBTrinity Biotech plc	B	D	C	0.1x	-16.6%	32.9%	—	$8.03
VNRXVolitionRx Limited	B	B	F	2.0x	86.3%	—	—	$0.18
CDIOCardio Diagnostics Holdings Inc. Common stock	—	D	C	345.9x	-25.9%	—	—	$1.69
QCLSQ/C Technologies, Inc. Common Stock	B	—	F	5.3x	—	24.7%	—	$0.54
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	F	—	—	—	—	$0.01

About Virax Biolabs Group Limited Ordinary Shares

Virax Biolabs is a biotechnology company specializing in immune response detection and viral disease diagnostics. The company offers research-use-only assays and immunology services through its ViraxImmune platform and ImmuneSelect portfolio. It is developing T cell-based diagnostic tests targeting post-acute infection syndromes, including Long COVID and other immune dysregulation-related conditions.